Skip to main content

Table 3 Unadjusted and adjusted odds ratio (OR) of characteristics independently associated with current use of highly effective contraception among HIV-positive respondents receiving antiretroviral therapy (ART) at 18 public sector clinic in Lusaka, Zambia (n = 4691)

From: Contraceptive use among HIV-infected women and men receiving antiretroviral therapy in Lusaka, Zambia: a cross-sectional survey

  Women Men
n = 1206 n = 295
Predictors Unadjusted OR Adjusted ORa Unadjusted OR Adjusted ORa
(95 % CI) (95 % CI) (95 % CI) (95 % CI)
Age (years)     
 15–24 ref ref b  
 25–34 1.25 (0.99–1.57) 0.92 (0.63–1.35) 0.97 (0.72–1.31)  
 35–49c 0.78 (0.59–1.04) 0.57 (0.38–0.87) ref  
  > 49    0.48 (0.29–0.80)  
Desire a child in the next year     
 Yes ref ref ref ref
 No/Don’t know 1.60 (1.25–2.06)* 2.28 (1.74–2.99)* 2.20 (1.65–2.94)* 2.89 (1.99–4.19)*
HIV status disclosed to partner     
 No/don’t know/no partner ref ref ref ref
 Yes 4.39 (3.32–5.80)* 2.32 (1.65–3.26)* 7.93 (2.87–21.95)* 7.32 (2.12–25.25)*
Partner’s HIV status     
 Negative/Don’t know/No partner ref ref ref  
 Positive 2.36 (2.05–2.71)* 1.44 (1.16–1.80)* 1.81 (1.33–2.46)  
Sexually active in previous 6 months     
 No ref ref ref ref
 Yes 3.19 (2.72–3.74)* 2.07 (1.62–2.65)* 2.14 (1.45–3.17)* 1.60 (0.95–2.70)
  1. Highly effective modern contraception includes oral contraceptive pills, injectables, sub-dermal implant, intrauterine device, and sterilization
  2. aThe estimation method was backward-selection multivariable logistic model (cluster standard error) with removal probability being ≥ 0.2
  3. bNo man aged 15–24 years used highly effective modern method
  4. cUsed as reference for men because 15–24 age category had no man using dual methods, making the age category highly unstable for referent
  5. * P-value < 0.01